Hainan Huluwa Pharmaceutical Group Co Ltd - Asset Resilience Ratio

Latest as of September 2021: 0.95%

Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has an Asset Resilience Ratio of 0.95% as of September 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 605199 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥14.00 Million

≈ $2.05 Million USD Cash + Short-term Investments

Total Assets

CN¥1.48 Billion

≈ $216.34 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Hainan Huluwa Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. See 605199 net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Hainan Huluwa Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Hainan Huluwa Pharmaceutical Group Co Lt stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥14.00 Million	0.95%
Total Liquid Assets	CN¥14.00 Million	0.95%

Asset Resilience Insights

Limited Liquidity: Hainan Huluwa Pharmaceutical Group Co Ltd maintains only 0.95% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Hainan Huluwa Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Hainan Huluwa Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%
Eris Lifesciences Limited NSE:ERIS	Drug Manufacturers - Specialty & Generic	0.58%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Lotus Pharmaceutical Co Ltd TW:1795	Drug Manufacturers - Specialty & Generic	0.49%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%

Annual Asset Resilience Ratio for Hainan Huluwa Pharmaceutical Group Co Ltd (None–None)

The table below shows the annual Asset Resilience Ratio data for Hainan Huluwa Pharmaceutical Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Hainan Huluwa Pharmaceutical Group Co Ltd

SHG:605199 China Drug Manufacturers - Specialty & Generic

Market Cap

$356.56 Million

CN¥2.44 Billion CNY

Market Cap Rank

#14087 Global

#4212 in China

Share Price

CN¥6.09

Change (1 day)

-0.65%

52-Week Range

CN¥6.09 - CN¥10.20

All Time High

CN¥48.21